MANAGEMENT OF NAUSEA AND VOMITING IN THE CANCER-PATIENT

被引:94
作者
FRYTAK, S
MOERTEL, CG
机构
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1981年 / 245卷 / 04期
关键词
D O I
10.1001/jama.245.4.393
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:393 / 396
页数:4
相关论文
共 19 条
  • [1] CHANG A, UNPUBLISHED
  • [2] DELTA-9-TETRAHYDROCANNABINOL AS AN ANTI-EMETIC IN CANCER-PATIENTS RECEIVING HIGH-DOSE METHOTREXATE - PROSPECTIVE, RANDOMIZED EVALUATION
    CHANG, AE
    SHILING, DJ
    STILLMAN, RC
    GOLDBERG, NH
    SEIPP, CA
    BAROFSKY, I
    SIMON, RM
    ROSENBERG, SA
    [J]. ANNALS OF INTERNAL MEDICINE, 1979, 91 (06) : 819 - 824
  • [3] COLLS BM, 1980, NEW ZEAL MED J, V91, P449
  • [4] DELTA-9-TETRAHYDROCANNABINOL AS AN ANTI-EMETIC FOR PATIENTS RECEIVING CANCER-CHEMOTHERAPY - COMPARISON WITH PROCHLORPERAZINE AND A PLACEBO
    FRYTAK, S
    MOERTEL, CG
    OFALLON, JR
    RUBIN, J
    CREAGAN, ET
    OCONNELL, MJ
    SCHUTT, AJ
    SCHWARTAU, NW
    [J]. ANNALS OF INTERNAL MEDICINE, 1979, 91 (06) : 825 - 830
  • [5] KHAN T, 1978, CANCER TREAT REP, V62, P1106
  • [6] KLUINNELEMAN JC, 1979, VET HUM TOXICOL, V21, P338
  • [7] DELTA-9-TETRAHYDROCANNABINOL FOR REFRACTORY VOMITING INDUCED BY CANCER-CHEMOTHERAPY
    LUCAS, VS
    LASZLO, J
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 243 (12): : 1241 - 1243
  • [8] LUTZ H, 1972, CURR THER RES CLIN E, V14, P178
  • [9] MOERTEL CG, 1969, GASTROENTEROLOGY, V57, P262
  • [10] MOERTEL CG, 1969, ADV GASTROINTESTINAL, P38